Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare Properties (HLTC) EBITDA Margin (2016 - 2025)

National Healthcare Properties (HLTC) has 13 years of EBITDA Margin data on record, last reported at 33.07% in Q4 2025.

  • For Q4 2025, EBITDA Margin fell 1244.0% year-over-year to 33.07%; the TTM value through Dec 2025 reached 23.99%, up 3546.0%, while the annual FY2025 figure was 23.99%, 3546.0% up from the prior year.
  • EBITDA Margin reached 33.07% in Q4 2025 per HLTC's latest filing, down from 20.64% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 4.33% in Q1 2021 and bottomed at 136.45% in Q2 2024.
  • Average EBITDA Margin over 5 years is 29.03%, with a median of 21.28% recorded in 2025.
  • Peak YoY movement for EBITDA Margin: plummeted -11869bps in 2024, then skyrocketed 10552bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 17.66% in 2021, then plummeted by -62bps to 28.57% in 2022, then plummeted by -62bps to 46.26% in 2023, then soared by 55bps to 20.63% in 2024, then plummeted by -60bps to 33.07% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 33.07% in Q4 2025, 20.64% in Q3 2025, and 30.93% in Q2 2025.